Over the past two decades, macroalgae have been presented as one of the most promising raw materials for improving the sustainability of aquafeeds. They are renewable resources, do not compete for agricultural land of freshwater, and can provide proteins, minerals, polysaccharides and bioactive compounds of interest.
For producers, however, the key question is not how much protein a macroalga contains, but how much growth, feed efficiency and profitability it can generate when incorporated into a commercial diet.
Recent findings in European seabass (Dicentrarchus labrax) juveniles suggest that some macroalgae can improve growth performance and feed efficiency without compromising the digestibility of proteins, lipids or energy.
This shift is significant because it moves the discussion beyond the simple replacement of conventional ingredients towards a more strategic question: the fish’s actual ability to utilise the ingredient.
That is where the main challenge lies. A proportion of the nutritional value of macroalgae may remain inaccessible because of their cell structures, complex polysaccharides, or the may nutrients are embedded within the algal matrix.
As a result, industrial interest will depend not only on producing large volumes of algal biomass, but also on developing processing technologies capable of improving the bioavailability of nutrients and functional compounds.
Bioavailability, feed efficiency and economic return per kilogram of feed consumed are therefore becoming more relevant indicators than the inclusion level of an alternative raw material.
In fish nutrition, a macroalga will not be valuable simply because of what it contains, but because of what the fish can convert into growth, health, feed conversion and production stability.
The economic factor will be decisive. Commercial aquafeed requires ingredients that are available in large volumes, supplied consistently and priced at levels compatible with industrial feed formulation.
If algal biomass or its processing increases feed costs, the resulting improvement in performance will need to clearly compensate for that additional expense. At present, the available evidence demonstrates biological potential, but the economic equation – cost, volume and productive return – has yet to be fully resolved.
In this context, the future of macroalgae-derived ingredients will depend less on their theoretical potential and more on the ability of science, technology and industry to unlock that potential under real farming conditions.